Trials / Completed
CompletedNCT00150540
A Long Term Study of Lanthanum Carbonate in Patients Requiring Dialysis Who Have Ived Lanthanum Carbonate in Previous Studies Defined by the Protocol.
A Long Term, Open Label Extension Study of Protocols LAM-IV-301, LAM-IV 303, LAM-IV 307 AND LAM-IV 308.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 93 (planned)
- Sponsor
- Shire · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety of lanthanum carbonate in patients undergoing dialysis who have received lanthanum carbonate in the previous studies and wish to continue treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lanthanum carbonate |
Timeline
- Start date
- 2002-10-14
- Primary completion
- 2005-06-29
- Completion
- 2005-06-29
- First posted
- 2005-09-08
- Last updated
- 2021-06-23
Source: ClinicalTrials.gov record NCT00150540. Inclusion in this directory is not an endorsement.